Delivery Order SPE2DB22D2211-SPE2DB25FRUCF
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$57K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,091.50 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $38,626.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 19, 2025. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of GEMTESA 75 MG TABLET 90S. The $1,340.85 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $61,756.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract is a delivery order for GEMTESA 75 MG TABLET 90S, with an ultimate completion date of November 14, 2024. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,473.21 Firm Fixed Price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a performance period through May 12, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,865.65, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, and has a completion date of November 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,459.09 delivery order contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of June 14, 2024 and is a firm fixed-price contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.08 firm fixed price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, with a completion date of May 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,699.26 firm fixed price delivery order covers the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a period of performance through January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and medical supplier. The $2,249.72 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a prescription drug product. The contract has an ultimate completion date of August 21, 2024 and is not set aside for any special program. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...